Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 1
1976 1
1978 3
1979 4
1980 2
1981 3
1982 4
1984 3
1986 3
1987 2
1990 2
1992 1
1997 1
2004 1
2005 2
2006 1
2009 1
2011 1
2012 9
2013 4
2014 1
2016 3
2017 1
2018 1
2019 5
2020 7
2021 20
2022 13
2023 12
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 34542988

97 results

Results by year

Filters applied: . Clear all
Page 1
Viloxazine.
[No authors listed] [No authors listed] 2021 Aug 20. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2021 Aug 20. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 34542988 Free Books & Documents. Review.
Attention Deficit/Hyperactivity Disorder (ADHD) Agents.
[No authors listed] [No authors listed] 2021 Aug 20. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2021 Aug 20. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 34542987 Free Books & Documents. Review.
A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder.
Nasser A, Hull JT, Chaturvedi SA, Liranso T, Odebo O, Kosheleff AR, Fry N, Cutler AJ, Rubin J, Schwabe S, Childress A. Nasser A, et al. CNS Drugs. 2022 Aug;36(8):897-915. doi: 10.1007/s40263-022-00938-w. Epub 2022 Jul 27. CNS Drugs. 2022. PMID: 35896943 Free PMC article. Clinical Trial.
Viloxazine in the Treatment of Attention Deficit Hyperactivity Disorder.
Edinoff AN, Akuly HA, Wagner JH, Boudreaux MA, Kaplan LA, Yusuf S, Neuchat EE, Cornett EM, Boyer AG, Kaye AM, Kaye AD. Edinoff AN, et al. Front Psychiatry. 2021 Dec 17;12:789982. doi: 10.3389/fpsyt.2021.789982. eCollection 2021. Front Psychiatry. 2021. PMID: 34975586 Free PMC article. Review.
Viloxazine: Pediatric First Approval.
Lamb YN. Lamb YN. Paediatr Drugs. 2021 Jul;23(4):403-409. doi: 10.1007/s40272-021-00453-3. Paediatr Drugs. 2021. PMID: 34036533 Free PMC article. Review.
97 results